Overall Technical outlook

*SUVENPHAR makes the list of companies with the worst fundamentals at present.

Price Summary

On 2025-07-16, SUVENPHAR's stock opened at 1059.0, reached a peak of 1071.95, dropped to 1054.4, and ended 0.45% higher at 1063.8, with a volume of 191992 shares.
In the last 52 weeks, the stock's top price was 1063.8 and the bottom price was 967.8.

Technicals

Support and Resistance: The current price for SUVENPHAR is 1063.8, supported at 1048.2 with resistance at 1113.1. This indicates a trading range where 1048.2 might prevent further declines, while 1113.1 could hinder additional gains.
SUVENPHAR supportResistance f08072
Support/Resistance for SUVENPHAR


Aroon: The AROON is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
SUVENPHAR aroon f08072
Aroon chart for Suven Pharmaceuticals Limited


Bol. Bands: The current price has recently crossed above the upper Bollinger Band, signaling a bullish move. This breakout suggests that buying interest is strong, pushing prices beyond their typical range. Traders may interpret this as a positive signal, indicating that the market might continue to rise as momentum builds.
SUVENPHAR bbands f08072
Bolinger Bands chart for Suven Pharmaceuticals Limited


Parabolic SAR: The PSAR remains bullish, establishing a key support level that could help uphold the market's upward trajectory. This persistent bullish outlook suggests that the market may continue to rise, with the support providing a foundation for further gains.
SUVENPHAR psar f08072
Parabolic Stop and Reverse chart for Suven Pharmaceuticals Limited


Stochastic: The stochastic indicator is in a bullish state, with the K-line crossing above both the D-line and the 80 mark. This alignment suggests strong upward momentum, implying that the market may continue its positive trajectory. Traders may see this as a sign of ongoing strength for Suven Pharmaceuticals Limited.
SUVENPHAR stoch f08072
Stochastic chart for Suven Pharmaceuticals Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
SUVENPHAR trippleSMA f08072
Tripple SMA chart for Suven Pharmaceuticals Limited


To derive valuable insights from a company's technical performance, it is essential to first understand its fundamentals. This includes its financial health, business model, and market share. Equally important is the industry context, such as competition, consumer demand, and market trends. By examining these aspects together, investors can gain a more comprehensive view of how the company's stock behaves and whether it's aligned with its underlying value.